Top 50 Medical VC Funds & Investors in Italy (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
CDP Venture Capital
VC Fund
|
16 | Italy, United States, Switzerland | Seed, Series A, Venture - Series Unknown | Software, Artificial Intelligence, Health Care | $483k–$23M |
|
Italian Angels for Growth
VC Fund
|
8 | Italy, United States, United Kingdom | Seed, Angel, Series A | Software, E-Commerce, Health Care | $219k–$14M |
|
Panakes Partners
VC Fund
|
6 | Italy, Switzerland, United Kingdom | Series B, Series A, Series C | Health Care, Medical, Biotechnology | $4.5M–$110M |
|
Innogest Capital
VC Fund
|
6 | Italy, United States, Spain | Series A, Venture - Series Unknown, Series B | Health Care, Medical, Medical Device | $1.1M–$32M |
|
LIFTT
VC Fund
|
5 | Italy, United Kingdom, France | Seed, Series A, Venture - Series Unknown | Biotechnology, Software, Health Care | $338k–$118M |
|
CDP Equity
VC Fund
|
4 | Italy, United States, United Kingdom | Seed, Series A, Pre-Seed | Information Technology, Software, Health Care | $177k–$13M |
|
Vertis
VC Fund
|
4 | Italy, United States, United Kingdom | Seed, Series A, Venture - Series Unknown | Software, Health Care, Biotechnology | $823k–$25M |
|
Invitalia Ventures
VC Fund
|
4 | Italy, United States, United Kingdom | Series A, Seed | Software, Medical, B2B | $292–$6.2M |
|
Indaco Venture Partners
VC Fund
|
4 | Italy, United Kingdom, Switzerland | Series A, Series B, Venture - Series Unknown | Biotechnology, Health Care, Medical | $2.3M–$89M |
|
Scientifica Venture Capital
VC Fund
|
3 | Italy, Sweden, Finland | Seed, Pre-Seed | Biotechnology, Health Care, Manufacturing | $209k–$2.9M |
|
Angelini Ventures
VC Fund
|
3 | United States, Italy, France | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $3.3M–$132M |
|
INGENIUM Emilia Romagna
VC Fund
|
3 | Italy | Seed, Series A, Angel | Medical, Biotechnology, Health Care | $663k–$2.8M |
|
XGEN Venture
VC Fund
|
3 | Italy, Sweden, Germany | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $4.6M–$141M |
|
Lazio Innova
VC Fund
|
3 | Italy, United Kingdom | Seed, Pre-Seed, Grant | Health Care, Software, Biotechnology | $22k–$1.9M |
|
Lumen Ventures
VC Fund
|
2 | Italy, United States | Seed, Series A, Pre-Seed | Health Care, Medical, Software | $1.4M–$14M |
|
Principia SGR
VC Fund
|
2 | Italy, United States, United Kingdom | Series A, Venture - Series Unknown | Health Care, Biotechnology, Software | $1.5M–$9.9M |
|
Equiter
VC Fund
|
2 | Italy | Seed, Series B | Medical, Health Care, Information Technology | $2.2M–$4M |
|
3B Future Health Fund
VC Fund
|
2 | United States, Italy, United Kingdom | Series B, Series A, Seed | Biotechnology, Therapeutics, Medical | $1.5M–$75M |
|
ENEA Tech e Biomedical
VC Fund
|
2 | Italy, Finland | Venture - Series Unknown, Series A, Grant | Health Care, Biotechnology, Medical Device | $530k–$21M |
|
P101
VC Fund
|
2 | Italy, Spain, United States | Seed, Series A, Venture - Series Unknown | Software, E-Commerce, Information Technology | $270k–$15M |
|
European Investment Bank
VC Fund
|
2 | France, Germany, Spain | Debt Financing, Post-IPO Debt, Venture - Series Unknown | Biotechnology, Energy, Health Care | $8.7M–$587M |
|
Club degli Investitori
VC Fund
|
2 | Italy, Switzerland, United Kingdom | Seed, Series A, Pre-Seed | Software, Health Care, E-Commerce | $197k–$30M |
|
Fondazione Social Venture Giordano dell'Amore
VC Fund
|
2 | Italy, Mexico | Venture - Series Unknown, Seed, Pre-Seed | Health Care, Software, Information Technology | $29k–$841k |
|
La Finanziaria Trentina
VC Fund
|
2 | Italy | Venture - Series Unknown, Private Equity | Health Care, Retail, Medical | $910k–$4.6M |
|
Neva SGR
VC Fund
|
2 | Italy, United States, Israel | Series B, Series A, Series C | Software, FinTech, Information Technology | $6M–$141M |
|
Antin Infrastructure Partners
VC Fund
|
2 | United States, Italy, United Kingdom | Private Equity, Seed | Energy, Renewable Energy, Commercial | $108M–$1B |
|
Alchimia Investments
VC Fund
|
2 | Italy, United Kingdom, Israel | Series A, Seed, Venture - Series Unknown | Software, Health Care, Medical | $2.3M–$40M |
|
The Techshop
VC Fund
|
2 | Italy, Portugal, Switzerland | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, FinTech | $322k–$120M |
|
Opes Italia
VC Fund
|
2 | Italy, Spain | Venture - Series Unknown, Series A, Seed | E-Commerce, Leisure, Medical | $440k–$7.5M |
|
Sefea Impact
VC Fund
|
2 | Italy | Venture - Series Unknown, Seed, Series A | Medical, Health Care, Information Services | $777k–$5.9M |
|
Fountain Healthcare Partners
VC Fund
|
2 | Ireland, United States, France | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $3.3M–$110M |
|
Fin Posillipo Spa
VC Fund
|
2 | Italy, United Kingdom | Seed, Pre-Seed, Venture - Series Unknown | Sales, Medical, Internet | $140k–$162k |
|
Evotec
VC Fund
|
2 | United States, Germany, United Kingdom | Series A, Seed, Series B | Biotechnology, Health Care, Therapeutics | $8.5M–$139M |
|
Fondazione Golinelli
VC Fund
|
1 | Italy | Seed, Pre-Seed, Grant | FinTech, Medical, Biotechnology | $146k–$534k |
|
GCM Group
VC Fund
|
1 | Italy | Seed | Medical, Genetics, Health Care | |
|
VI Partners
VC Fund
|
1 | Switzerland, Germany, United States | Series A, Series B, Series C | Health Care, Biotechnology, Software | $3.3M–$100M |
|
Green Arrow Capital
VC Fund
|
1 | Italy, United States, United Kingdom | Seed, Series A | Software, Health Care, Manufacturing | $300k–$2.5M |
|
Padda Health
VC Fund
|
1 | Italy, Germany, Luxembourg | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Artificial Intelligence, Medical | $244k–$2.6M |
|
Sviluppo Imprese Centro Italia
VC Fund
|
1 | Italy | Seed, Angel | Software, Food Processing, Food and Beverage | $584k–$668k |
|
UniCredit
VC Fund
|
1 | Italy, Germany, United States | Debt Financing, Post-IPO Debt, Pre-Seed | Renewable Energy, Energy, Manufacturing | $197k–$2.1B |
|
Sistema Investimenti
VC Fund
|
1 | Italy | Seed, Series A | Mobile, Medical, Health Care | $500k–$2.1M |
|
V-Bio Ventures
VC Fund
|
1 | Belgium, France, United States | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $3.1M–$88M |
|
Fondazione Cottino
VC Fund
|
1 | Italy | Seed | Medical, mHealth, Diabetes | |
|
Embed Capital
VC Fund
|
1 | Italy, Switzerland, United Kingdom | Seed, Venture - Series Unknown, Pre-Seed | Information Technology, Mobile, Software | $130k–$2.1M |
|
SIMEST
VC Fund
|
1 | Italy | Grant, Series A, Series B | Manufacturing, Coffee, Aerospace | |
|
50 Partners Health
VC Fund
|
1 | ||||
|
EISMEA
VC Fund
|
1 | Spain, Switzerland, United Kingdom | Grant, Seed, Venture - Series Unknown | Biotechnology, Software, Health Care | $54k–$9M |
|
Exceptional Ventures
VC Fund
|
1 | United Kingdom, Italy, France | Convertible Note, Seed, Pre-Seed | Health Care, Food and Beverage, Biotechnology | |
|
RoboIT
VC Fund
|
1 | Italy | Pre-Seed | Medical, Manufacturing, Medical Device | |
|
Growth Engine
VC Fund
|
1 | Italy, Mexico, United Kingdom | Seed, Secondary Market, Convertible Note | Software, E-Commerce, Information Technology | |
| Access all 188 VC funds in Italy Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Italy, United States, Switzerland
Investor stats
- Total investments: 301
- Round size: Seed $483k–$8.1M; Series A $3.3M–$23M; Venture - Series Unknown $652k–$16M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $212M in 2021
Portfolio highlights
- Evja — Evja supports growers in optimizing the management and monitoring of irrigation, nutrition and protection of their crops through the use of OPI, the most advanced system for precision agriculture .
- Aptadir Therapeutics — Reprogramming DNA methylation in disease conditions by RNA therapeutics APTADIR Contact us NEWS Press Release Reprogramming DNA methylation by RNA therapeutics A novel therapeutic approach for untreatable cancers and rare diseases Aberrant methylation by DNA methyltransferase 1 (DNMT1) of certain genes may cause abnormal cell development and lead to disease. Current therapies targeted to inhibit
- Tretau — E-mobility is powered by its core - the electric motor. We at Tau are at the very core of the core: the copper winding wire, the magnetic core, the electrical steel.We just make it bet.
IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Angel, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 106
- Round size: Seed $331k–$5.1M; Angel $219k–$987k; Series A $3M–$14M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Cato AI — Search, analyze and bid on Italian public tenders with AI, automating the manual work for bid offices and sales teams.
- AUDIOGEN — Generate your sounds with AI. Create an infinite world of sounds - sound effects, samples, and music, instantly. Get Started Free.
- Alomana — Autonomous systems for enterprise
Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250million under management.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 42
- Round size: Series A $4.5M–$79M; Series B $10M–$60M; Series C $18M–$110M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely still investing — raised $187M in 2023
Portfolio highlights
- Neuromod Devices — Neuromod is the global medical device company that developed Lenire, the FDA Approved tinnitus treatment device.
- DISCO Pharmaceuticals — DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
- Endovascular Engineering — Endovascular Engineering is a medical technology company focused on developing and deploying advanced clot removal solutions for the treatment of venous thromboembolism. It specializes in thrombectomy technologies designed to improve clinical outcomes and procedural efficiency in minimally invasive vascular interventions. The company’s flagshipinnovation is the Hēlo™ Thrombectomy System, a catheter-based device that uses a combination of mechanical agitation and physician-controlled aspiration to remove blood clots. Its technology emphasizes features such as a self-expanding funnel design and dual-action functionality to enhance clot engagement and navigation through complex anatomies. Endovascular Engineering primarily serves healthcare providers, including interventional cardiologists and radiologists, supporting the treatment of conditions such as pulmonary embolism and deep vein thrombosis.
We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Venture - Series Unknown, Series B
- Geography: Italy, United States, Spain
Investor stats
- Total investments: 68
- Round size: Series A $1.1M–$11M; Series B $2.7M–$32M; Venture - Series Unknown $1.6M–$12M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $95M in 2015
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Renovacor — Renovacor is a preclinical‑stage biopharmaceutical company focused on developing transformative gene therapy‑based treatments for cardiovascular disease.Renovacor’s lead program is a recombinant adeno-associated virus (AAV)‑based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the Bcl2‑associatedathanogene 3 (BAG3) gene.Dilated cardiomyopathy is a condition affecting over 3 million patients in the US and growing steadily. Many patients develop DCM due to ischemic heart disease. Recently subpopulations have been identified that develop DCM due to mutations in specific genes that have been shown to result in the development of DCM. One of these specific genes is the BAG3 gene. The prevalence of disease‑causing BAG3 haploinsufficiency is estimated at approximately 35,000 individuals in the United States, representing an orphan disease by FDA guidelines. It is estimated a similar number of DCM patients with BAG3 mutations exist in Europe. These patients are typically younger and progress to end-stage heart failure sooner than patients with ischemic heart disease. Currently, DCM patients with a BAG3 mutation are treated with standard of care for heart failure. Despite improvements in pharmacotherapy and care, the five‑year survival of a patient with DCM is only 50%. The development of a BAG3 gene replacement therapy for patients with DCM that carry BAG3 mutations could potentially prevent the progression of disease in this otherwise healthy population of young adults.
- BetaGlue Technologies — BetaGlue Technologies engage in the research and offers anticancer products.
A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Italy, United Kingdom, France
Investor stats
- Total investments: 75
- Round size: Seed $338k–$4.7M; Series A $2.8M–$21M; Venture - Series Unknown $495k–$118M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- CareGlance — CareGlance is the provider of real-time monitoring systems based on SS-OCT technology. Fast, precise and developed for the industry!
- Rainbow Crops — Rainbow Crops is a next-generation Agtech company developing climate-resilient, high-performing crop varieties.
- Wearable Robotics — Wearable Robotics produces and develops wearable robotic systems and exoskeletons for rehabilitation, assistance and human-power augmentation.
CDP Equity is a holding company that has been set up to boost the Italian economy by investing venture capital in companies of "significant national interest" (as envisaged by the decrees of the Ministry of Economy and Finance of 3 May 2011 and 2 July 2014) or in companies with "economic, financial and capital balance, with adequateprospects of profitability and development, capable of generating value for investors"
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 41
- Round size: Seed $177k–$3.6M; Pre-Seed $230k–$3.6M; Series A $2.3M–$13M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Gility — Gility is a digital learning platform that collaborates with business schools and training institutions for an effective training offer. Established in 2022, it was supported by CDP Venture Capital and BPER Banca.
- Soplaya — Soplaya is a B2B food company connecting chefs and farmers to build a diverse, sustainable, and efficient food system.By providing data and transparency to an opaque supply chain, we help chefs to simplify purchases, get a wider selection of products and save money and farmers to increase their margins and get easy access to the market.We lovequality food as much as technology and automation. We are rebels: we love transparency and how the internet is capable of bringing the long tail to the market. We're excited about the fact that the restaurant supply chain hasn't basically changed since 40 years, and was technology reluctant for a long time, but restaurants necessities changed dramatically in the last 3 years.We’re becoming the standard layer for restaurant purchasing across Europe, by bringing transparency and simplicity in the procurement phase, increasing order frequency, promoting lean inventory and food waste reduction.
- Valvitalia SpA. — VALVITALIA is a leading group in the field of design, production, and overall supply of equipment and components intended for the petroleum, water, natural gas industries, and petrochemical industry as well as electrical power stations. The group works mainly with valves (core product), actuators, pipe fittings, flanges and systems for measuring,filtering, and regulating fluids and gases and with FireFighting systems. VALVITALIA was set up with the precise objective of becoming the leading Italian group able to offer such a wide range of products and to compete with the large American multinationals that have always dominated this field. This young company has extensive experience in the sector, thanks to its professional management and historical brands in the valve world that have been taken on by the Group, including: ROTOR, DELTA V.E., THEVIGNOT, VANADOUR, VITAS, TORMENE T.G.T. and TECNOFORGE. VALVITALIA has always included safety and respect for the environment and its employees among its priorities.
Capitali e competenze per accelerare l'innovazione. Attraverso fondi di investimento chiusi investiamo in startup, scaleup e PMI innovative
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 76
- Round size: Seed $823k–$4M; Series A $1.5M–$11M; Venture - Series Unknown $1.1M–$25M
- Lead/follow: 54% lead, 46% follow
- Last fund: May invest from a new fund soon — raised $49M in 2021
Portfolio highlights
- Clastix — Kubernetes multi-tenancy made easy
- Tiledesk — Boost customer engagement with Tiledesk. Discover our conversational automation ready to use. Personalized experiences, improved conversion and retention.
- Comestai — Comestai focuses on digital and in-person treatment pathways for people with eating disorders. The company operates a hybrid care model that combines online consultations with psychologists, psychotherapists, psychiatrists, and clinical dietitians and access to physical clinical spaces. It offers virtual multidisciplinary therapy programs tailoredto individuals and families, with structured assessments and follow-up sessions. Comestai also develops corporate welfare programs that provide counseling groups, psychoeducational tools, and consultation modules for employees in partner organizations. Through its La Palestra di Animenta branch, it delivers structured professional training, including multi-module courses and continuing medical education pathways for clinicians treating eating disorders. Comestai additionally produces digital educational content such as the Hilde newsletter to support families and caregivers with practical information and clinical guidance about eating disorders.
Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation. Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it
Show more...Investment focus
- Industry: Software, Medical, B2B
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 30
- Round size: Seed $292–$1.6M; Series A $900k–$6.2M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — raised $103M in 2017
Portfolio highlights
- Ecomate — The ESG Rating platform for every company
- BigProfiles — BigProfiles is an Artificial Intelligence Platform designed for Utilities, Telcos, Banks, Insurance companies and Retails.Large companies such as Teleperformance, Eni, Unicef already have already successfully subscribed to our services.BigProfiles is the No-Code Artificial Intelligence Platform for sales and antichurn that predicts thelikelihood to purchase and churn of each customer in a CRM, before proceeding to contact him in a sales or retention campaign.
- Codemotion — Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers.
VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Italy, United Kingdom, Switzerland
Investor stats
- Total investments: 49
- Round size: Series A $3.5M–$33M; Series B $8.9M–$89M; Venture - Series Unknown $2.3M–$21M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $302M in 2018
Portfolio highlights
- Newcleo — newcleo is the clean and safe nuclear technology company. Privately funded and headquartered in London, UK, newcleo was launched in 2021 to be a disruptor in the field of nuclear energy. Its mission is to generate safe, clean and inexhaustible energy for the world, through a radically innovative combination of existing, accessible technologies.newcleo is building the next generation system with the goals to: (1) eliminate the need for geological repositories by using a fast neutron flux avoiding production of long life radioactive elements; (2) develop an Accelerator Driven System (ADS), based on the intrinsically safe coupling of a particle accelerator and a sub-critical reactor; (3) accelerate the development of new fuel cycles, including thorium, that provide economic, clean, safe and inexhaustible energy from nuclei and the opportunity to burn the long-lived nuclear waste produced by the old generation of nuclear reactors.With visionary co-founders, newcleo brings together a team of engineers with deep knowledge of nuclear energy with younger recruits with a fresh mindset, working to design an innovative micro Lead Fast Reactor with significant commercial applications, for example in shipping. newcleo wants to be the first step toward the evolution of its industry to become fully respectful of people and the environment. To develop a new, sustainable, and completely safe way of generating nuclear energy that will lead humanity to zero emissions, and to the mitigation of global warming.
- Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
- Aptadir Therapeutics — Reprogramming DNA methylation in disease conditions by RNA therapeutics APTADIR Contact us NEWS Press Release Reprogramming DNA methylation by RNA therapeutics A novel therapeutic approach for untreatable cancers and rare diseases Aberrant methylation by DNA methyltransferase 1 (DNMT1) of certain genes may cause abnormal cell development and lead to disease. Current therapies targeted to inhibit
Scientifica Venture Capital offers private equity and venture capital investment services for Italy based startups and firms.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Seed, Pre-Seed
- Geography: Italy, Sweden, Finland
Investor stats
- Total investments: 17
- Round size: Seed $209k–$2.9M; Pre-Seed $209k–$541k
- Lead/follow: 76% lead, 24% follow
- Last fund: Likely actively investing — fresh fund, raised $209M in 2024
Portfolio highlights
- Relicta — Relicta solution is a water-soluble bioplastic material obtained from fish processing waste and suitable for packaging solutions.
- OhmSpace — OhmSpace provides the satellite market with reliable resistojets.
- LOTO Biotech — LOTO Biotech is a biotechnology platform focused on supporting the development of treatments for rare diseases, particularly those caused by dominant negative genetic mutations.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Angelini Ventures is an investment firm.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: United States, Italy, France
Investor stats
- Total investments: 35
- Round size: Seed $3.3M–$45M; Series A $11M–$105M; Series B $19M–$132M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
- Epicrispr Biotechnologies — The Gene Expression Modulation System (GEMS) technology from Epic-Bio combines a DNA-binding protein, a tailored guide RNA, and any of a wide range of modulator proteins to generate a powerful new type of genetic medicine. GEMS medicines have the ability to precisely modify gene expression both in and out of the body. They are mutation-independent,which means that a single GEMS design can address the majority or all genetic subtypes of a disease.
- Aptadir Therapeutics — Reprogramming DNA methylation in disease conditions by RNA therapeutics APTADIR Contact us NEWS Press Release Reprogramming DNA methylation by RNA therapeutics A novel therapeutic approach for untreatable cancers and rare diseases Aberrant methylation by DNA methyltransferase 1 (DNMT1) of certain genes may cause abnormal cell development and lead to disease. Current therapies targeted to inhibit
INGENIUM Emilia Romagna was started with EUR 5.30 million by the Emilia Romagna region and EUR 1.7 million from fund managers. Managed by META Investment, the nine-year fund operated through the temporary acquisition of minority stakes in high-opportunity technological companies. It is now fully invested.
Show more...Investment focus
- Industry: Medical, Biotechnology, Health Care
- Stage:Seed, Series A, Angel
- Geography: Italy
Investor stats
- Total investments: 8
- Round size: Seed $663k–$2.8M; Series A $1.1M–$2.2M
- Lead/follow: 63% lead, 37% follow
Portfolio highlights
- Fazland — Smart solutions to daily problems.
- Passpack — Users can make and store passwords in a single, organized list, then access them from anywhere leaving no traces behind on the computer. Secure collaboration features allow users to make, send, share or provision passwords to colleagues, clients and partners -- a secure alternative to spreadsheets in the workplace. Managed via a central onlinerepository.Passpack is a free, professional tool. Optional premium upgrades are available for the micro-small business sector.
- GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
XGEN Venture is an Italian alternative investment fund manager (Società di Gestione del Risparmio, or SGR) with over 15 years of experience in the startup process and the development of innovative solutions for high unmet medical needs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: Italy, Sweden, Germany
Investor stats
- Total investments: 11
- Round size: Series A $11M–$98M; Series B $4.6M–$141M
- Lead/follow: 55% lead, 45% follow
- Last fund: Likely actively investing — fresh fund, raised $186M in 2024
Portfolio highlights
- Dialybrid — Dialybrid provide product that include silkothane arteriovenous graft, SAG biomimetic nanostructure, and situ tissue engineering products. Their proprietary innovative technology, silkothane, is a hybrid material combining silk fibroin and polyurethane. Their aim is to develop a novel semi-degradable vascular access for hemodialysis.
- EpilepsyGTx — EpilepsyGTx is a late-stage biotech company exploring cutting-edge gene therapies to improve the management of focal refractory epilepsy (FRE).
- Aptadir Therapeutics — Reprogramming DNA methylation in disease conditions by RNA therapeutics APTADIR Contact us NEWS Press Release Reprogramming DNA methylation by RNA therapeutics A novel therapeutic approach for untreatable cancers and rare diseases Aberrant methylation by DNA methyltransferase 1 (DNMT1) of certain genes may cause abnormal cell development and lead to disease. Current therapies targeted to inhibit
Lazio Innova is a venture capital firm with its headquarters in Rome in Italy. The firm provides services in areas such as credit support and guarantees, interventions in risk capital, internationalization services, promotion of business networks and services for the creation and enterprise development.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Pre-Seed, Grant
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 35
- Round size: Seed $400k–$1.9M; Grant $22k–$343k; Pre-Seed $58k–$518k
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $27M in 2018
Portfolio highlights
- HEU — Draft, sign and store contracts in one place. AI extracts deadlines and clauses, signatures valid in 180+ countries.
- Tech4All — We support the study by using AI.
- GeneSys Bio — Antimicrobial Resistance (AMR) is a global health emergency projected to cause 10 million deaths annually by 2050. The crisis is fueled by slow, conventional diagnostics that take 3-5 days, forcing the empirical use of broad-spectrum antibiotics and accelerating the spread of superbugs.GeneSys Bio is commercialising a breakthrough solution: afully automated, sample-to-result molecular diagnostic platform that identifies infectious pathogens and their critical antibiotic resistance genes in under 30 minutes with >99% sensitivity and specificity. Our portable, laptop-sized device combines proprietary nucleic acid amplification with an AI-driven engine to deliver clear, actionable results directly to clinicians, veterinarians, and public health officials.Our platform is a modular "One Health" solution, adaptable via disease-specific kits for human, veterinary, and environmental applications. We are entering the market with a diagnostic for Urinary Tract Infections (UTIs), a condition affecting over 500 million people annually and a primary driver of antibiotic misuse. By enabling targeted therapy at the first patient encounter, our platform is set to reduce treatment costs by up to 13%, cut follow-up visits, and decrease mortality from complicated infections by 50%.GeneSys Bio is positioned to capture a significant share of this market by bridging the critical gap between speed, laboratory-grade accuracy, and accessibility. We are not just creating a device; we are building the future of decentralized infectious disease diagnostics to safeguard global health for generations to come
Lumen Ventures is a venture capital firm that focuses on seed investments, early-stage investments, and private equity.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: Italy, United States
Investor stats
- Total investments: 11
- Round size: Seed $1.4M–$5.3M; Series A $5.3M–$14M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $29M in 2020
Portfolio highlights
- qomodo — Qomodo: La piattaforma BNPL innovativa. Rate a tasso zero, approvazioni veloci, transazioni sicure. Rivoluzionaria nell'acquisto per aziende e consumatori.
- Serenis Health — Serenis Health provides video-based psychotherapy, coaching, and psychological support courses. It believes that the internet is critical to increasing access to mental health care. It makes use of data and digital tools to improve the efficacy of therapies. But, unlike other platforms, it is also a medical center, which means it is responsible forcourse quality and must meet the same standards as any polyclinic.
- AutoConnexa — Scopri AutoConnexa, l'assicurazione online per la tua auto che premia lo stile di guida. Con Drive Connexa, meglio guidi e meno paghi.
Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Venture - Series Unknown
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 50
- Round size: Series A $1.5M–$7.9M; Venture - Series Unknown $7.2M–$9.9M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $200M in 2014
Portfolio highlights
- KLISBio — KLISBio is a clinical-stage regenerative medicine company focused on developing innovative technology platforms based entirely on natural silk fibroin. The company, headquartered in Milan, Italy, currently has several assets under development, such as vascular graft, bone graft substitutes, rotator cuff repair, drug release, and a first-in-humanstudy on nerve repair that is ongoing at the University of Zurich, Switzerland
- ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
Equiter seleziona, realizza e gestisce investimenti infrastrutturali in capitale di rischio finalizzati allo sviluppo socio-economico del territorio.
Show more...Investment focus
- Industry: Medical, Health Care, Information Technology
- Stage:Seed, Series B
- Geography: Italy
Investor stats
- Total investments: 8
- Round size: Seed $2.2M–$4M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Busforfun — Shared and Green traveling to experience the world of fun#WeTheFun | Busforfun is a young mobility company traveling in a sustainable, safe and low-cost way across Europe. Busforfun vision is a green and shared mobility to experience the world of fun.#WeTheTech | Busforfun is a combination of high tech-startup, e-commerce-platform andtransportation company, Busforfun is going to establish European largest bus network for events in the short time. Thanks to a powerful search engine, business intelligence, an user-friendly booking system and an extensive route network, Busforfun offers travellers the opportunity to experience the world of fun with lower fares.#WeTheGreen | Our low-emission buses comply with the highest safety and environmental standards, so Busforfun offers a sustainable and convenient alternative to cars. With main partner Treedom, Busforfun plants new trees at any travel worldwide.Live Fun Experience in partnership – our concept for successBusforfun provides customers with great offers at lowest budget, through smart network planning, dynamic price management and an adaptive web engine.Busforfun platform is where the innovation and start-up spirit meet the experience and know-how of traditional bus companies and travel agencies.Incredible success can be attributed to the digitalization of old-fashioned bus travel industry: Busforfun has not suppliers or clients: but partners only!
- Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
- Faccin Group — Faccin Group leads in manufacturing top tier metal forming & bending machines. Operating as Faccin, Roundo & Boldrini, we offer unparalleled expertise.
Helsinn Investment Fund S.A. is a Luxembourg fund focused on early-stage investments in areas of high unmet patient need.
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Medical
- Stage:Series B, Series A, Seed
- Geography: United States, Italy, United Kingdom
Investor stats
- Total investments: 40
- Round size: Seed $1.5M–$11M; Series A $2.8M–$41M; Series B $7.4M–$75M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- GenEp — GenEp, Inc. is a pre-clinical stage biotechnology company based on intellectual property assets. GenEp creates therapies targeting mutations of sodium and other ion channels that cause rare genetic epilepsies and other treatment-resistant epilepsies.
- Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
- Navion Neurosciences — Navion Neurosciences is a preclinical-stage biotechnology company developing next-generation, precision sodium channel therapies for neurological diseases.
ENEA Tech e Biomedical is a private foundation. It seeks to encourage the strengthening of research, development, and industrial reconversion of the biomedical sector.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Venture - Series Unknown, Series A, Grant
- Geography: Italy, Finland
Investor stats
- Total investments: 13
- Round size: Series A $3.3M–$7.7M; Venture - Series Unknown $530k–$21M
- Lead/follow: 92% lead, 8% follow
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
- Recornea — Recornea is a developer of a corneal medical device to restore the physiological curvature of the cornea with clear and predictable clinical outcomes.
- Health Triage — Health Triage, crea nuove tecnologie per offrire modelli innovativi di diagnosi clinica, identificazione e cura delle malattie oncologiche.
P101 is an Italian venture capital firm focused on early-stage investments in the digital sector. Agreement to handle personal data I agree I don't agree
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Italy, Spain, United States
Investor stats
- Total investments: 121
- Round size: Seed $270k–$4M; Series A $2.3M–$15M; Venture - Series Unknown $721k–$8.2M
- Lead/follow: 63% lead, 37% follow
- Last fund: Likely still investing — raised $265M in 2022
Portfolio highlights
- Biorsaf — Biorsaf is an IT company that develops mobile apps and web control panels to assist companies to bring efficiency to their operations.
- Cosmico — We are the platform connecting digital talents with the most ambitious companies, using remote work.We have over 8,000 members and our talents have accelerated dozens of projects alongside big names like Accenture Song, Tangity, Frog, Fjord, Sketchin, EY but also aggressive start-ups like Scalapay, Gimme5, Flowe, Unguess.If you are a digitalprofessional: we offer you a community in which to grow your talent through experiences, networks and cosmic projects.If you are a company: we offer you access to a community of designers, developers and marketers from which to select the talents to accelerate your digital transformation projects. Whether you are a manager or a digital professional, Cosmico is here to help you find your space
- A-Cube — A-Cube API: la piattaforma globale per la Tax Compliance. Integra la fatturazione elettronica e gli obblighi fiscali in ogni ERP o e-commerce in Italia e nel mondo.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Energy, Health Care
- Stage:Debt Financing, Post-IPO Debt, Venture - Series Unknown
- Geography: France, Germany, Spain
Investor stats
- Total investments: 595
- Round size: Post-IPO Debt $18M–$587M; Debt Financing $16M–$355M; Venture - Series Unknown $8.7M–$90M
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- VaxThera — VaxThera develops and produces vaccines to prevents and treats diseases.
- Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
- Reactive Technologies — Reactive Technologies we are committed to enabling a more intelligent use of energy, for the largest and most complex business to the smallest household. Our aim is to develop new technologies that will positively assist the energy industry to deliver cleaner, greener and more affordable energy, through more efficient and effective energymanagement and control. Through our innovative, cloud-based solution for Corporate customers – Tradenergy® – we have begun this process and with our pipeline of ground breaking new technologies we intend to continue.
Club degli Investitori (Investors Club) is a network of investors and business angels that invest on early-stage SMEs and startups. The community of 300+ Members (entrepreneurs, CEOs, executive managers) actively scouts for investing opportunities on SMEs & startups and invests with a minimum ticket of €200k. The Club supports business byinvesting capital and by leveraging the Members' network and experience.Club degli Investitori is supported by Unicredit and KPMG Italy.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Series A, Pre-Seed
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 118
- Round size: Seed $197k–$8.4M; Pre-Seed $204k–$1.9M; Series A $889k–$30M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Soource — Soource is a B2B Saas product that uses AI applications to help purchasing managers to discover the best market solutions through extensive global research and automated email negotiations with thousands of suppliers worldwide.
- Comestai — Comestai focuses on digital and in-person treatment pathways for people with eating disorders. The company operates a hybrid care model that combines online consultations with psychologists, psychotherapists, psychiatrists, and clinical dietitians and access to physical clinical spaces. It offers virtual multidisciplinary therapy programs tailoredto individuals and families, with structured assessments and follow-up sessions. Comestai also develops corporate welfare programs that provide counseling groups, psychoeducational tools, and consultation modules for employees in partner organizations. Through its La Palestra di Animenta branch, it delivers structured professional training, including multi-module courses and continuing medical education pathways for clinicians treating eating disorders. Comestai additionally produces digital educational content such as the Hilde newsletter to support families and caregivers with practical information and clinical guidance about eating disorders.
- Aptadir Therapeutics — Reprogramming DNA methylation in disease conditions by RNA therapeutics APTADIR Contact us NEWS Press Release Reprogramming DNA methylation by RNA therapeutics A novel therapeutic approach for untreatable cancers and rare diseases Aberrant methylation by DNA methyltransferase 1 (DNMT1) of certain genes may cause abnormal cell development and lead to disease. Current therapies targeted to inhibit
FSVGDA aims at the promotion of the impact investing culture, in order to facilitate social innovation.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Venture - Series Unknown, Seed, Pre-Seed
- Geography: Italy, Mexico
Investor stats
- Total investments: 31
- Round size: Seed $205k–$603k; Venture - Series Unknown $29k–$841k
- Lead/follow: 65% lead, 35% follow
Portfolio highlights
- C.NEXT — C.NEXT develops innovation projects for businesses and organizations by supporting the economy and territorial regeneration.
- Vivavoce — Il centro medico Vivavoce, Specializzato nel trattamento riabilitativo della #balbuzie. Disturbi del Linguaggio, DSA, Psicologia e Neuropsichiatria infantile.
- Way Experience — Way Experience operates in all the entertainment B2C sectors, using augmented and virtual reality technology. They also work in the B2B area by applying their technologies for customized consultancy projects in the following sectors: design, fashion, medical, events, and training.
La Finanziaria Trentina is s a private equity firm. It invests in energy, infrastructure, and real estate sectors.
Show more...Investment focus
- Industry: Health Care, Retail, Medical
- Stage:Venture - Series Unknown, Private Equity
- Geography: Italy
Investor stats
- Total investments: 12
- Round size: Venture - Series Unknown $910k–$4.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- VENPA — Noleggio Piattaforme Aeree e Noleggio Macchine Movimento Terra. Scopri tutti i mezzi da cantiere Venpa!
- Tony Kart — Tony Kart is an automotive company specializing in designing and manufacturing chassis, OTK kart parts, and karting wears.
- Hippocrates — Hippocrates operates a pharmacy platform with a network of over 120 owned pharmacies concentrated in central and northern Italy. Since its foundation, it has approached the pharmacy sector with an industrial and long-term logic. The company was founded in March 2018 by Davide Tavaniello and Rodolfo Guarino, co-CEOs of Hippocrates.
Neva SGR, part of the Intesa Sanpaolo Group and wholly owned by the Intesa Sanpaolo Innovation Center, plans and manages investment funds for professional investors interested in seizing diversification and high-yield opportunities offered by Venture Capital investments. Neva SGR can count on Intesa Sanpaolo Innovation Center’s and Intesa SanpaoloGroup’s strength, financial resources, know-how and network of relationships, a unique source of value on the market. Neva SGR is the perfect blend of strength, reputation and stability of the Intesa Sanpaolo Group and the best practices of international venture capital firms. Neva SGR aims to boost the Italian economy through new technologies and to be market maker of the VC asset class of venture capital in Italy.
Show more...Investment focus
- Industry: Software, FinTech, Information Technology
- Stage:Series B, Series A, Series C
- Geography: Italy, United States, Israel
Investor stats
- Total investments: 52
- Round size: Series A $6M–$64M; Series B $17M–$141M; Series C $28M–$110M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- iwoca — Iwoca provides financing to businesses for various purposes, including bridging short-term cashflow gaps and investing in stock opportunities. It services retailers, restaurants, hotels, and other businesses. It offers flexible repayment options from 1 day to 24 months, with no penalties for early repayment. Iwoca helps businesses manage cash flowgaps and invest in growth opportunities, enhancing their financial capabilities.
- Straiker — Security for agentic AI applications built from the ground up with fine-tuned models to protect and secure every layer of your agentic AI stack.
- Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
Antin Infrastructure Partners is a leading private equity firm focused on infrastructure investments.
Show more...Investment focus
- Industry: Energy, Renewable Energy, Commercial
- Stage:Private Equity, Seed
- Geography: United States, Italy, United Kingdom
Investor stats
- Total investments: 16
- Round size: Private Equity $108M–$1B
- Lead/follow: 69% lead, 31% follow
- Last fund: Likely still investing — raised $1.3B in 2023
Portfolio highlights
- CityFibre — CityFibre is a brand new full fibre network built for the data age. Never worry about speed or reliability again. Connect your home and business today.
- Power Dot — Powerdot offers electric vehicle charging solutions in convenient locations across six European countries.
- Origis Energy — Origis Energy is powering the solar revolution with solar power and energy storage projects for utility, corporate and public sector energy clients.
Alchimia is an investment company primarily operating in the Venture Capital Sector. Leveraging the expertise of our team and a wide network of international advisors, we invest and co-invest in high growth potential opportunities offering capital, as well as dedicated strategic and operational resources.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Italy, United Kingdom, Israel
Investor stats
- Total investments: 21
- Round size: Seed $2.3M–$11M; Series A $4.4M–$40M; Venture - Series Unknown $5.8M–$14M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Gardin — We believe in a world in which everyone has the right to access high quality, nutritious food that is good for you and for our planet. Our environmental issues are real, something, somewhere needs to change. Gardin promises to create the step-change required by deploying its technology.
- NoTraffic — NoTraffic has developed the first AI-powered traffic signal platform that connects road...
- Stellar — At Stellar we bring perfect internet on the move to vehicles and passengers, leveraging the combined strength of cellular, wi-fi, and satellite networks, through AI and fully integrated solutions. We offer SaaS, data plans, and all-inclusive options for enterprise connectivity needs on the move.
The Techshop is a venture capital and private equity firm that invests in B2B digital startups.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, Portugal, Switzerland
Investor stats
- Total investments: 29
- Round size: Seed $2M–$8.1M; Pre-Seed $322k–$37M; Series A $7.7M–$120M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- CiaoDott — Automatizza le telefonate, prenotazioni e FAQ del tuo studio medico con CiaoDott, l'assistente vocale AI disponibile 24/7. Provalo gratis.
- Octostar — Octostar is the sovereign, AI-powered investigative intelligence platform for law enforcement, national security and financial institutions.
- Helix Robotics — We are building the first commercial soft manipulator
Opes Italia Sicaf Euveca is an impact investing Venture Capital fund. Our aim is to invest in companies based in Italy, or with prevalent activity in the country, and that propose solutions that generate a strong social impact and create positive externalities for the community and the territory.
Show more...Investment focus
- Industry: E-Commerce, Leisure, Medical
- Stage:Venture - Series Unknown, Series A, Seed
- Geography: Italy, Spain
Investor stats
- Total investments: 13
- Round size: Seed $440k–$536k; Series A $2.3M–$7.5M; Venture - Series Unknown $2.2M–$4.9M
- Lead/follow: 77% lead, 23% follow
Portfolio highlights
- Baluwo — Providing basic essentials has never been this easy. Sending money is not always the solution so we provide easy, fast & convenient ways to send prepaid electricity top-ups, mobile top-ups and basic food items to support your family back home in The Gambia, and very soon in Senegal and Nigeria.
- Freedome — Freedome is the leading marketplace for outdoor activities in Italy
- GenomeUp — Rome-based healthtech startup that offers an ecosystem of AI-powered solutions for genetic analysis and clinical decision support for diseases. GenomeUp's mission is to be a global reference platform to support clinical decision-making for hospitals, laboratories, research centers, and pharmaceuticals to accelerate diagnosis times, improvepatient care and provide knowledge for health prevention, all in less than 24h. Based on these assumptions, the founders decided to evolve the startup and transform it into a Italian Benefit Corporation following the purpose of common benefit by acting responsibly, sustainably and transparently towards stakeholders, people, communities, the territory and the environment.
Sefea Impact is an asset management company that setting up and managing closed-end alternative investment funds. It aims to generate social impacts through fundamental tools such as tailored finance, technical assistance, and impact measurement.
Show more...Investment focus
- Industry: Medical, Health Care, Information Services
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: Italy
Investor stats
- Total investments: 8
- Round size: Venture - Series Unknown $777k–$5.9M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Evja — Evja supports growers in optimizing the management and monitoring of irrigation, nutrition and protection of their crops through the use of OPI, the most advanced system for precision agriculture .
- BionIT Labs — BionIT Labs is an Italian-U.S. company developing prosthetic and robotic technologies built around how humans move, perceive, and interact with the physical world.
- Planeat.eco — Planeat.eco is the site where you can plan your food shopping in a simple and economical way, starting from the recipes and receiving at home all the ingredients ready for preparation , weighed and divided into compostable containers. They offer their products online.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: Ireland, United States, France
Investor stats
- Total investments: 57
- Round size: Series A $6.3M–$35M; Series B $5.5M–$68M; Series C $3.3M–$110M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $140M in 2019
Portfolio highlights
- Palyon Medical — Palyon Medical Corporation is a medical device company developing technologies for the treatment of chronic pain, spasticity and other neurological diseases.
- Neuromod Devices — Neuromod is the global medical device company that developed Lenire, the FDA Approved tinnitus treatment device.
- Vivasure Medical — Pioneering the Future of Large-Bore Vessel Closure for Arterial and Venous Access. The first and only 100% bio-absorbable, sutureless patch..
Familiy Office of Petrone Group
Show more...Investment focus
- Industry: Sales, Medical, Internet
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 4
- Round size: Pre-Seed $140k–$162k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Verado — Verado is a global technology platform designed to empower everyone to instantly monetize their belongings. Whether selling an old laptop or unlocking cash by collateralizing valuables for a loan, our technology is crafted to enable consumers to do so with unprecedented ease. Snap a picture of your electronics, valuables, apparel or otherbelongings, get an instant appraisal through our real time valuation engine, and receive a direct payout to your bank account immediately. We are a deep technology company, envisioning a world where products’ lifecycle is lengthened and the ecological burden of trashing minimised. What exists currently is falling short of the experience modern consumers expect. They value convenience, comfort and speed, and don’t deem existing selling channels even marginally satisfactory. They are tired of the tedious paper-work, negotiating with uncommitted buyers through outdated messaging systems, managing the logistics, and the time-consuming nature of the process. Through our innovative solutions, we are cutting down from days to seconds the time it takes to receive a valuation; and from weeks to hours, the time necessary to sell!Verado is changing the rules of the game - It’s simplicity, re-engineered. We believe selling should be as seamless as buying. Therefore, rather than accumulating unused products at home or worse letting them end up in a landfill forever - we enable individuals to monetize their unwanted things, free up valuable space in their home and reduce their need for borrowing whilst simultaneously minimizing their ecological footprint.
- BetaGlue Technologies — BetaGlue Technologies engage in the research and offers anticancer products.
Evotec is a global biotechnology company committed to advancing drug discovery & development together with our partners for medicines that matter.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Seed, Series B
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 29
- Round size: Series A $8.5M–$95M; Series B $21M–$139M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Aptadir Therapeutics — Reprogramming DNA methylation in disease conditions by RNA therapeutics APTADIR Contact us NEWS Press Release Reprogramming DNA methylation by RNA therapeutics A novel therapeutic approach for untreatable cancers and rare diseases Aberrant methylation by DNA methyltransferase 1 (DNMT1) of certain genes may cause abnormal cell development and lead to disease. Current therapies targeted to inhibit
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
- Aeovian Pharmaceuticals — Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.
Fondazione Golinelli was born in Bologna in 1988 by the will of the entrepreneur and philanthropist Marino Golinelli with the aim to promote education and training, to promote the culture, to foster intellectual growth and ethics of young people, the citizens of tomorrow.
Show more...Investment focus
- Industry: FinTech, Medical, Biotechnology
- Stage:Seed, Pre-Seed, Grant
- Geography: Italy
Investor stats
- Total investments: 7
- Round size: Seed $146k–$534k
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Biorfarm — Adotta il tuo Albero, crea il tuo Campo Digitale e ricevi a domicilio la tua frutta biologica. Solo con Biorfarm puoi seguire la crescita dei tuoi frutti!
- EvenFi — Criptalia uses blockchain technology to connect businesses that have projects to be funded with people and organizations who are looking for high-yield investments. We offer an online platform where companies publish their innovative ideas and industrial improvement projects. Investors, people, and institutions can fund these projects by lendingmoney in exchange for a higher interest rate.
- Latitudo40 — Empower sustainable growth with AI-driven satellite insights from Latitudo 40. Unlock precise, real-time data for smarter urban planning, climate risk management, and industry innovation. Enhance resilience and lead with confidence.
GCM Group is an investment firm.
Show more...Investment focus
- Industry: Medical, Genetics, Health Care
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- GenomeUp — Rome-based healthtech startup that offers an ecosystem of AI-powered solutions for genetic analysis and clinical decision support for diseases. GenomeUp's mission is to be a global reference platform to support clinical decision-making for hospitals, laboratories, research centers, and pharmaceuticals to accelerate diagnosis times, improvepatient care and provide knowledge for health prevention, all in less than 24h. Based on these assumptions, the founders decided to evolve the startup and transform it into a Italian Benefit Corporation following the purpose of common benefit by acting responsibly, sustainably and transparently towards stakeholders, people, communities, the territory and the environment.
Vi Partners is a venture capital firm backing exceptional founders in healthcare and technology across Switzerland and Europe for over 25 years.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Series C
- Geography: Switzerland, Germany, United States
Investor stats
- Total investments: 113
- Round size: Series A $3.5M–$23M; Series B $3.3M–$41M; Series C $7M–$100M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $110M in 2020
Portfolio highlights
- Nexthink — Discover what your employees need, see what they experience, know how they feel. Deliver IT that delights.
- Pay by Shopping (deal united) — paybyshopping.com Domain Name is available to Buy. Grab this great Domain from Daaz. Daaz has the lowest transaction fees in the industry. See our list of GTLD's,CCTLD's, New GTLD's,3N's, 6N's, 3L's, 6L's etc.
- Sonic Emotion — Sonic Emotion Absolute 3DTM sound technology provides an innovative unique solution for an immersive natural 3D sound reproduction by implementing audio products with sound field control from only 2, 3, 4 or 6+ channels using a single compact device (and an optional subwoofer internal or external).
Piattaforma indipendente italiana leader negli investimenti alternativi.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 12
- Round size: Seed $300k–$2.5M; Series A $1.5M–$2.2M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — raised $267M in 2018
Portfolio highlights
- Pieralisi — Pieralisi is provides revolutionized traditional olive oil extraction systems, conquering domestic and international markets with the first decanter for olive-oil continuous processing.
- Maticmind S.p.A — Maticmind S.p.A is a company that provides ICT and system integration solutions to telecommunications operators.
- Green Future Project — B Corp climate tech che supporta le aziende a raggiungere il net zero e diventare un'azienda sostenibile, riducendo l'impatto ambientale.
Siamo partner di private equity con una struttura family office. Selezioniamo start-up tech-driven con idee innovative e voglia di emergere.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Medical
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Italy, Germany, Luxembourg
Investor stats
- Total investments: 6
- Round size: Seed $1.4M–$2.6M; Pre-Seed $244k–$285k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- TeiaCare — TeiaCare is an Italian start-up born in 2018 with the aim of transferring technology and innovation knowledge to care homes.Our first solution, Ancelia, is an AI-powered operating system designed to increase transparency in the care and assistance processes, both inside the care home and towards residents' families.TeiaCare, based inMilan, operates in Italy and Spain, has a team of 15 people and is supported by international investors.
- VoiceMed — We bring deep-tech innovation into your smartphone. With vocal biomarkers and artificial intelligence, we measure respiratory diseases.
- Hale — Hale is the digital solution supporting people with genito-pelvic pain, helping them live better with their condition. Download our app now!
Sviluppo Imprese Centro Italia is an independent asset management company founded in Florence in 1998. Active in the Private Equity and Venture Capital sector, it currently manages four closed-end funds for a total value of around 140 million euro and has already carried out numerous operations. in the capital of companies operating in variousindustrial sectors, from the most traditional to high-tech. The mission of SICI is to encourage the development of unlisted SMEs in Central Italy through the contribution of financial resources intended to strengthen their capital and financial structure. SICI intends to represent a Growth Partner for the investee companies and a strategic operator in the creation of value for the territory with an impact on the economic and social fabric in terms of competitiveness of the economic system, employment, entrepreneurial and managerial culture. Business Development Central Italy is an independent Italian managing closed-end funds company. Established in Florence in 1998, SICI has 4 Private Equity and Venture funds under management with a total committed capital of 140m Euros.
Show more...Investment focus
- Industry: Software, Food Processing, Food and Beverage
- Stage:Seed, Angel
- Geography: Italy
Investor stats
- Total investments: 17
- Round size: Seed $584k–$668k
- Lead/follow: 53% lead, 47% follow
Portfolio highlights
- Recuperiamo srl — Recuperiamo srl is a food industry founded to prevent and reduce waste throughout the food chain. They are involved in the food industry through the Regusto brand. They can use geolocation to report on last-minute offers for their dishes.
- Dora Bruschi 1934 — Dora Bruschi 1934 is a cosmetics company that provides cosmetics, beauty, and make-up products with tailor-made formulas.
- Gastronomia Toscana — Gastronomia Toscana is a food company that manufactures and supplies a wide range of pre-cooked meals.
UniCredit is a pan-European commercial bank offering unique banking services in Italy, Germany, Central and Eastern Europe.
Show more...Investment focus
- Industry: Renewable Energy, Energy, Manufacturing
- Stage:Debt Financing, Post-IPO Debt, Pre-Seed
- Geography: Italy, Germany, United States
Investor stats
- Total investments: 154
- Round size: Pre-Seed $197k–$197k; Post-IPO Debt $44M–$2.1B; Debt Financing $552k–$913M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Ludoil — Ludoil is an energy company that offers production, storage, logistics, and marketing services for oil products
- Banxware — Banxware provides the technology and the funds for business financing of any kind: fully embedded in your platform or as an affiliate solution - all managed by Banxware
- Encavis — The Encavis AG is listed in the SDAX segment of the German stock exchange and is a producer of electricity from renewable energy sources. As one of the leading independent power producers, They acquire and operate solar and wind parks throughout Europe. Their plants generate stable returns and make an important contribution to safe and clean energysupplies.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Sistema Investimenti is an holding in the form of SpA, established by the will of young professionals and entrepreneurs in Sicily. Sistema Investimenti focus on qualified minorities primarily in companies in the South of Italy with the exception of turnaround/restructuring and distressed.
Show more...Investment focus
- Industry: Mobile, Medical, Health Care
- Stage:Seed, Series A
- Geography: Italy
Investor stats
- Total investments: 3
- Round size: Seed $500k–$2.1M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Pedius — Pedius is a communication system that allows deaf people to make normal phone calls. Use it in your everyday life to make important calls such as booking doctors appointments or making reservations, or to call family, friends and coworkers.Once you download the smartphone app you can start a conversation by either typing or speaking a message.The recipient will listen on their end and reply, and you will immediately read a transcription of what he or she just said. Pedius gives you the freedom to have real-time conversations when you need to call a plumber, book a table at your favourite restaurant, or talk to your doctor.The Pedius app is especially useful when you need to contact someone accessible only by phone, and it is an excellent help when you need to be careful about your privacy.
- Ganiza.me — Ganiza.me is a developer of a social planning application.
- Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.
V-Bio Ventures is an independent venture capital firm specialized in building and financing young, innovative life science companies. The fund invests throughout Europe in start-up and early-stage companies with high growth potential focusing on technologies that provide transformational improvements in the biotech, pharmaceutical and agriculturalsectors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: Belgium, France, United States
Investor stats
- Total investments: 45
- Round size: Seed $3.1M–$50M; Series A $6.9M–$70M; Series B $12M–$88M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — raised $131M in 2021
Portfolio highlights
- Animab — Animal Health Company
- RootWave — RootWave is an electronics company that develops tools that kill weeds it enables farmers to control weeds on their farm. Its technology is an alternative substitute for herbicides and other weed control chemicals. The company was founded in 2012 and headquartered in Warwickshire, United Kingdom.
- Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
Fondazione Cottino is support young people in their educational path and support for scientific research, technology transfer.
Show more...Investment focus
- Industry: Medical, mHealth, Diabetes
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- D-EYE — D-EYE's technology enables healthcare professionals all over the world to quickly screen for problems, photograph them and then distribute them digitally via various secure wireless solutions. They design and manufacture diagnostic instruments.
Embed Capital directly invests in startups, established or in the process of creation.Embed is mainly focused on innovative companies that:- Are active in the so-called “real economy” sectors: industrials, technology, environment, services, retail or social;- Are characterized by simple and intuitive business models and valuepropositions, and operate in markets or market segments featuring high growth potential;- Present a clear competitive advantage and high barriers-to-entry;- Are cash-generative in the medium term.Given that Embed Capital is not a closed-end fund, it doesn’t have specific time-constrains and it can assess on a project-by-project basis to determine the best time to sell a participation, and sign customized agreements with the entrepreneurs.
Show more...Investment focus
- Industry: Information Technology, Mobile, Software
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 17
- Round size: Seed $130k–$2.1M; Venture - Series Unknown $454k–$734k
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Piantando — Piantando sells plants connected to initiatives for the preservation of the planet engaged in the following areas: land, water, climate, biodiversity and local communities. Each plant is equivalent to a transparent and unique contribution, destined to an initiative certified by our Value Chain. Everyone become ambassadors of a new way of livinggreen and understanding their commitment to the planet.
- FrescoFrigo - Healthy food close to you — FrescoFRIGO is a smart fridge with fresh and quality products designed for the needs of worker. Improve everyday lifestyle, through automated proximity selling of good, fresh and healthy product, innovating technology and user experience.
- The Nemesis — The Nemesis is the playground for play-to-earn games and adventures in virtual worlds. Accessible on both mobile and desktop.
SIMEST is a financial firm focused on the development and promotion of Italian enterprises abroad. Simest acquires up to 49% of the equity capital of foreign firms in countries outside the European Union, whether wholly-owned by Italian companies or set up as joint ventures with local partners. It also provides start-up and growth capital financingas well as participating in buyouts.Geographically it invests in non-EU countries, focusing on BRIC, Americas and Middle-East. Simest also provides Italian companies seeking to internationalize their businesses with technical assistance and advisory services.Simest is a member of the European Development Finance Institutions (EDFI) and the Italian Venture Capital and Private Equity Association (AIFI).
Show more...Investment focus
- Industry: Manufacturing, Coffee, Aerospace
- Stage:Grant, Series A, Series B
- Geography: Italy
Investor stats
- Total investments: 7
- Lead/follow: no public data
Portfolio highlights
- hlpy — hlpy operates as a roadside assistance company. Hlpy provides a digital roadside assistance service via a network of 580+ centers, 1,900+ drivers/mechanics, 2,800+ tow trucks.
- Objectway — Powered by over 30 years of business expertise in delivering wealth and asset management technology and services, Objectway empowers its clients to embrace their future challenges while providing great performance today.Objectway solutions and services enable opti-channel customer engagement, front-office productivity, stronger investmentperformance, suitable advice and compliance enforcement, efficient back-office operations and automation, pro-active client reporting and management analytics.Our front-to-back, multi-channel, scalable, cloud-ready platform leverages a component-based architecture with AI-driven algorithmic engines for risk & performance analytics, real-time investment compliance, portfolios optimisation and mass customisation, with open APIs for easy integration.Objectway is a Global Top 100 fintech provider (IDC ranking) and our clients include 200+ leading wealth managers, banks, asset managers, fund managers, insurers and outsourcing providers in more than 15 countries. We support approximately 100,000 investment professionals to manage more than £1 trillion in assets.Objectway operates from offices in Italy, UK, Ireland and Belgium serving customers in 4 continents.
- BionIT Labs — We apply IT to Bionics in order to Turn disabilities into New Possibilities
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Medicud — Medicud develops a device for treating wounds with negative pressure dressing.
Executive Agency for SMEs
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Grant, Seed, Venture - Series Unknown
- Geography: Spain, Switzerland, United Kingdom
Investor stats
- Total investments: 176
- Round size: Seed $54k–$2.3M; Grant $57k–$2.8M; Venture - Series Unknown $1.4M–$9M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- AGADE — Esoscheletri Agade | Il primo esoscheletro intelligente per lavoratori progettato per ridurre il rischio di disturbi muscolari delle spalle nella movimentazione manuale dei carichi.
- BroadBit Batteries — BroadBit is a technology company developing revolutionary new batteries using novel sodium-based chemistries to power the future green economy.
- Aenitis Technologies — We develop innovative devices for cells therapy processing using Acoustic Radiation Forces.
Exceptional Ventures is an early-stage venture capital firm that invests in entrepreneurs and businesses that improve people's lives. Founded in 2022 and is based in London, England.
Show more...Investment focus
- Industry: Health Care, Food and Beverage, Biotechnology
- Stage:Convertible Note, Seed, Pre-Seed
- Geography: United Kingdom, Italy, France
Investor stats
- Total investments: 25
- Lead/follow: no public data
Portfolio highlights
- ReportAId — ReportAId is an AI-powered software that breathes life into medical reports to make healthcare more organized, customized, and accessible.
- Jove Insurance — Jove provides business and protection insurance to contractors, freelancers and SMEs, powered by tech and driven by social good.
- Alba Health — Discover your baby's gut health & microbiome for the best start in life.
RoboIT is the National Technology Transfer Hub for Robotics and Industrial Automation.
Show more...Investment focus
- Industry: Medical, Manufacturing, Medical Device
- Stage:Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 7
- Lead/follow: no public data
Portfolio highlights
- SunCubes — SunCubes is an innovative startup developing wireless energy transmission technologies using lasers, enabling applications like drone recharging and remote sensor power, driving efficiency.
- Eye2Drive — EYE2DRIVE is a young company designing and building a new imaging sensor for the autonomous cars. We are based in Tuscany, Italy.
- PhotonPath — Enabling seamless integration between Photonics and Electronics for a faster, more connected and sustainable future
Growth Engine is a Venture Capital holding investing in Pre-Seed and Seed high-potential opportunities. With a current portfolio of more than 40 companies, most of them evolved in successful Scaleups, Growth Engine is a diversified asset class by sector and stage. Growth Engine Shareholders are entrepreneurs who have built companies from the groundup, collectively creating billions in value, and top executives managing companies with multi-billion-dollar valuations.
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Secondary Market, Convertible Note
- Geography: Italy, Mexico, United Kingdom
Investor stats
- Total investments: 45
- Lead/follow: no public data
Portfolio highlights
- BonusX — Con l'app BonusX hai un supporto anti-burocrazia tutto l'anno. Accedi a centinaia di bonus e servizi pubblici, senza stress e code.
- WithLess — Apps multiply, costs grow, admin spirals. We get it. The tools your team needs WithLess time, money, and admin.
- Vivaio Ventures — Vivaio Ventures partners with early-stage and creator-led consumer brands to scale food, beverage, and beauty products. We offer capital, consulting, and Made in Italy manufacturing excellence for the next CPG leaders.
Medical VC funding in Italy at a glance
Stats across 176 deals from 188 investors.
Access all 188 VC funds in Italy Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical VC Funds in Italy investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 188 VC funds investing in Italy Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!